Jnana Therapeutics

OMass Therapeutics

This company develops small molecule therapeutics for patients with immunological and rare diseases using a proprietary native mass spectrometry platform.

Kymera Therapeutics

This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.

Nimbus Therapeutics

This clinical-stage biotechnology company develops small molecule medicines for patients with cancer, immunology, and metabolic diseases using an AI-enhanced computational discovery engine.

Gain Therapeutics

This biotechnology company develops allosteric small molecule therapies for patients with neurodegenerative diseases and rare genetic disorders using an artificial intelligence drug discovery platform.

TRIANA Biomedicines

This company develops molecular glue therapeutics for patients with cancer and other diseases using a discovery platform and computational tools.

Nimbus

This clinical-stage company develops small molecule medicines for patients with cancer, inflammatory diseases and metabolic disorders through a computational drug discovery engine.

Reax

This company develops chemical proteomic platform technologies to discover small molecule therapeutics for patients with cancer and immunological diseases.

Vividion

The company develops small-molecule medicines for patients with cancer and immune disorders using a proprietary chemoproteomics platform to target previously undruggable proteins.